甲状腺功能减退与老年人群死亡率的关联:系统综述与荟萃分析
该系统综述与荟萃分析检索多个数据库至2019年5月10日,纳入27项队列研究共1 114 638名年龄≥60岁的参与者,评估甲状腺功能减退与全因及心血管死亡率的关联。结果显示甲状腺功能减退患者全因死亡风险高于甲状腺功能正常者(合并RR=1.26,95%CI:1.15-1.37),心血管死亡率无显著差异(合并RR=1.10,95%CI:0.84-1.43)。
要点
- 老年甲状腺功能减退患者全因死亡风险升高(合并RR=1.26,95%CI:1.15-1.37)。
- 心血管死亡率在甲状腺功能减退与甲状腺功能正常者间无显著差异(合并RR=1.10,95%CI:0.84-1.43)。
- 显性甲状腺功能减退与全因死亡率升高相关(合并RR=1.10,95%CI:1.01-1.20),亚临床甲状腺功能减退无显著关联(合并RR=1.14,95%CI:0.92-1.41)。
核心结论
- 基于当前证据,在老年人群中甲状腺功能减退与全因死亡率升高显著相关,而与心血管死亡率无显著关联。
- 观察到相当大的异质性,解释结果时需谨慎;需要进一步的前瞻性、大规模、高质量研究来证实这些发现。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、Embase、Cochrane Library、Scopus和Web of Science数据库自建库至2019年5月10日。
- 纳入评估年龄≥60岁老年人群中甲状腺功能减退与全因和/或心血管死亡率关联的研究,共纳入27项队列研究,1 114 638名参与者。
- 由两名评价者独立提取数据并评估研究质量,提取相对风险(RR)进行合成,采用随机效应模型进行荟萃分析。
主要发现
- 甲状腺功能减退患者全因死亡风险高于甲状腺功能正常者(合并RR=1.26,95%CI:1.15-1.37)。
- 甲状腺功能减退患者与甲状腺功能正常者心血管死亡率无显著差异(合并RR=1.10,95%CI:0.84-1.43)。
- 亚组分析显示显性甲状腺功能减退与全因死亡率升高相关(合并RR=1.10,95%CI:1.01-1.20),而亚临床甲状腺功能减退无显著关联(合并RR=1.14,95%CI:0.92-1.41)。
- 异质性主要来源于不同的研究设计(前瞻性和回顾性)和地理位置(欧洲、北美、亚洲和大洋洲)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 观察到相当大的异质性,解释结果时需谨慎。
- 需要进一步的前瞻性、大规模、高质量研究来证实这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The evidence of whether hypothyroidism increases mortality in the elderly population is currently inconsistent and conflicting. OBJECTIVE: The objective of this meta-analysis is to determine the impact of hypothyroidism on mortality in the elderly population. DATA SOURCES: PubMed, Embase, Cochrane Library, Scopus, and Web of Science databases were searched from inception until May 10, 2019. STUDY SELECTION: Studies evaluating the association between hypothyroidism and all-cause and/or cardiovascular mortality in the elderly population (ages ≥ 60 years) were eligible. DATA EXTRACTION: Two reviewers independently extracted data and assessed the quality of the studies. Relative risk (RR) was retrieved for synthesis. A random-effects model for meta-analyses was used. DATA SYNTHESIS: A total of 27 cohort studies with 1 114 638 participants met the inclusion criteria. Overall, patients with hypothyroidism experienced a higher risk of all-cause mortality than those with euthyroidism (pooled RR = 1.26, 95% CI: 1.15-1.37); meanwhile, no significant difference in cardiovascular mortality was found between patients with hypothyroidism and those with euthyroidism (pooled RR = 1.10, 95% CI: 0.84-1.43). Subgroup analyses revealed that overt hypothyroidism (pooled RR = 1.10, 95% CI: 1.01-1.20) rather than subclinical hypothyroidism (pooled RR = 1.14, 95% CI: 0.92-1.41) was associated with increased all-cause mortality. The heterogeneity primarily originated from different study designs (prospective and retrospective) and geographic locations (Europe, North America, Asia, and Oceania). CONCLUSIONS: Based on the current evidence, hypothyroidism is significantly associated with increased all-cause mortality instead of cardiovascular mortality among the elderly. We observed considerable heterogeneity, so caution is needed when interpreting the results. Further prospective, large-scale, high-quality studies are warranted to confirm these findings.
引用
- Tsai TY, Tu YK, Munir KM, et al. Association of Hypothyroidism and Mortality in the Elderly Population: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2020. PMID: 31829418. doi:10.1210/clinem/dgz186
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。